Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-14
DOI
10.1038/s41598-017-06327-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA
- (2017) Xin Yang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-free DNAs in Blood
- (2017) Jinfeng Zou et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- PIK3CAmutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
- (2016) S. Loibl et al. ANNALS OF ONCOLOGY
- The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival
- (2016) Ines Vasconcelos et al. BREAST
- Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients
- (2016) Firoz Ahmad et al. MEDICAL ONCOLOGY
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
- (2016) Ebubekir Dirican et al. TUMOR BIOLOGY
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
- (2016) Jacob J. Chabon et al. Nature Communications
- Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
- (2016) Ji-Yeon Kim et al. Cancer Research and Treatment
- PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
- (2015) Chiya Oshiro et al. BREAST CANCER RESEARCH AND TREATMENT
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- The influence of subclonal resistance mutations on targeted cancer therapy
- (2015) Michael W. Schmitt et al. Nature Reviews Clinical Oncology
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients
- (2015) Jiaxin Niu et al. OncoTargets and Therapy
- Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
- (2015) Xun Yuan et al. PLoS One
- Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer
- (2014) L. M. Arthur et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks
- (2013) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance
- (2013) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- Signaling Network Assessment of Mutations and Copy Number Variations Predict Breast Cancer Subtype-Specific Drug Targets
- (2013) Naif Zaman et al. Cell Reports
- Analysis of PIK3CA Mutations in Breast Cancer Subtypes
- (2013) Ruza Arsenic et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
- (2012) Nicholas A. Saunders et al. EMBO Molecular Medicine
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer
- (2009) Matthew J. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
- (2009) K. Kalinsky et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started